The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ELEVEN BIOTHERAPEUTICS, INC. | COM | 286221106 | 5,084 | 4,841,591 | SH | DFND | 1,2,3 | 4,841,591 | 0 | 0 | |
| ZAFGEN, INC. | COM | 98885E103 | 1,567 | 210,371 | SH | DFND | 1,2,3 | 210,371 | 0 | 0 | |
| CYTOMX THERAPEUTICS, INC. | COM | 23284F105 | 29,029 | 1,020,348 | SH | DFND | 1,2,3 | 1,020,348 | 0 | 0 | |
| KALA PHARMACEUTICALS INC. | COM | 483119103 | 26,190 | 1,654,425 | SH | DFND | 1,2,3 | 1,654,425 | 0 | 0 | |
| RHYTHM PHARMACEUTICALS, INC. | COM | 76243J105 | 79,231 | 3,981,437 | SH | DFND | 1,2,3 | 3,981,437 | 0 | 0 | |